
    
      The present study will enroll a cohort of randomized patients from the TWILIGHT trial at the
      Mount Sinai Medical Center. These subjects will undergo blood sampling and measurement of
      thrombotic indices at the time of randomization and 1-6 months thereafter.
    
  